Commentary

Article

State of the Science Summit - Hematologic Malignancies: Chaired by Minoo Battiwalla, MD, MS

State of the Science Summit - Hematologic Malignancies: Chaired by Minoo Battiwalla, MD, MS

State of the Science Summit - Hematologic Malignancies: Chaired by Minoo Battiwalla, MD,MS

Speakers

  • Clark Cutrer, MD | University of Tennessee Medical Center
  • Radhakrishnan Ramchandren, MD| University of Tennessee Medical Center
  • Stephen Strickland, MD | Sarah Cannon Transplant & Cellular Therapy Program at TriStar Centennial
  • Farrukh Awan, MD | UT Southwestern Medical Center
  • Jeremy Pantin, MD | Sarah Cannon Transplant & Cellular Therapy Program at TriStar Centennial

Topics

  • Navigating BTK Inhibitors in CLL
  • How Targeted Therapies Are Used in FL
  • Updates in Myeloid Malignancy
  • Bispecifics in DLBCL
  • Controversies in CAR T
  • Updates in Multiple Myeloma

Interested in virtually attending an IPC event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science SummitsClick here to listen to our latest episodes!

Related Videos
Justin M. Watts, MD
Mazyar Shadman, MD, MPH
Craig Eckfeldt, MD, PhD, assistant professor, medicine, faculty, Microbiology, Immunology, and Cancer Biology PhD Graduate Program, Division of Hematology, Oncology, and Transplantation, the University of Minnesota Medical School
Mark Juckett, MD, professor, medicine, Division of Hematology, Oncology, and Transplantation, the University of Minnesota Medical School
Timothy Hughes, MD, MBBS, FRACP, FRCPA
Hannah Choe, MD, an expert on GVHD
Hannah Choe, MD, an expert on GVHD
Grzegorz S. Nowakowski, MD
Video 8 - 2 KOLs are featured in, "Emerging Trials in the Management of HR+/HER2- mBC"
Video 7 - 2 KOLs are featured in, "Adverse Event Data and Management for Optimal Quality of Life in HR+/HER2- mBC"